Puma Biotechnology Inc (NYSE:PBYI)
| 211.08 Data as of Jan 30 |  -4.99 / -2.31%Today’s Change | 53.63 Today|||52-Week Range 279.37 | +11.52% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Assets | Cash | 462.00 | -- | 137.4M | 43.0M | |
| Short Term Investment Cash | -1.9K | 53.4M | 84.0M | -94.4M | ||
| Cash & Short Term Investments | 462.00 | 53.4M | 137.4M | 83.9M | ||
| Receivables | Receivables | 0.00 | 0.00 | 10.6M | 9.8M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 0.00 | -- | -- | 554.0K | |
| Other Current Assets | 0.00 | 281.1K | 952.0K | 2.1M | ||
| Current Assets | 462.00 | 53.7M | 149.0M | 96.4M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 692.8K | 1.8M | 2.4M | |
| Depreciation | -- | -10.7K | -276.0K | -699.0K | ||
| Other Assets | 0.00 | 0.00 | 36.0K | 5.1M | ||
| Total Assets | 462.00 | 55.4M | 151.7M | 104.4M | ||
| Liabilities | Accounts Payable | 0.00 | 86.7K | 482.0K | 10.7M | |
| Accrued Expenses | -- | 190.6K | 20.4M | 7.5M | ||
| Other Current Liabilities | 0.00 | 190.6K | 20.4M | 7.5M | ||
| Other Liabilities | 0.00 | 586.2K | 21.7M | 19.3M | ||
| Total Liabilities | Total Liabilities | 0.00 | 1.0M | 22.8M | 20.4M | |
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 462.00 | 54.4M | 128.9M | 84.0M | ||
| Total Shareholder Equity | 462.00 | 54.4M | 128.9M | 84.0M | ||
| Share Information | Common Shares Outstanding | 3.0M | 20.0M | 28.7M | 29.0M | |
| Addtl. Info. | No data currently available for this section. | |||||
.